Pharm Exam 1: Section 2 Flashcards
Renin Angiotensin System
Maintains homeostasis in euvolemic state
Stimulated in low volume or low O2 state –> Sympathetic NS
Kidneys hold onto sodium and create thirst which increases volume and smooth muscle contraction
Increases BP and increases tissue perfusion in arterioles
If local tissue injury, A2 arrives and promotes vascular inflammation
Remodeling of cardiac and vascular tissues in myocardium occurs
Increased fibrous products in tissues –> hypertrophy
Hypertrophy –> CHF
ACEI Benzapril Captopril Enalapril Lisinopril
ARBS
Losartan
Valsartan
ACEI block Ace enzyme to prevent conversion of A1 to A2
ARBS don’t work on A2, work to block receptors for A2 at tissue level
Bradykinin: at high levels in lung –> cough
Prostaglandins: ACEI -> angioedema
ACEI and black people
Black people make less renin than other groups
ACEI less effective
ACEI & ARBS
How they work
Decrease production of A2 and aldosterone
Prevent vascular smooth muscle contraction -> decrease afterload (arteries)
Decrease Na and H2O retention in kidney -> decrease preload (veins) - less volume in system
Reduce vascular inflammation & remodeling bc A2 and its mechanisms are blocked
Aldosterone tells kidney to hold onto Na and K -> H2O follows salt - > increased volume. ACEI and ARBS block this mechanism
ACEI & ARBS
Pharmacokinetics
Well absorbed PO; better on empty stomach. Ok with food
Most are prodrugs (not active in own form but when they get to liver, they break down into metabolites that are active form)
* Must be used in people with intact hepatic system
* lisinopril & captopril not prodrugs
Used alone and in combo with diuretics -> tends to improve efficacy
ACEI & ARBS
Pharmacokinetics
Renal protection: decrease arterial resistance in glomeruli; when blood comes through kidney
Mild Insulin sensitization: ACEI & ARBS help cells recognize and use insulin- good for DM
Most excreted renal: used in pts w/ early renal failure and microalbuminuria in DM. If pt has more advanced renal failure, start at low dose, check electrolytes in 1 week to ensure no high K
Distributed to all tissues except CNS
Cross placenta, are in breast milk.
ACEI & ARBS
Adverse reactions
No reflex tachycardia bc no impact on CO
Hypotension
High K if dose too high
Cough: dry; don’t give another ACEI, can try ARB
-Cross -sensitivity so can happen with ARBS
Angioedema: typically when combined with other drugs like macrolides (zpack)
- Occurs in face, mainly lips and mouth, sometimes forehead
- If occurs, stop macrolide, stop ACEI for a couple of days
- If just on ACEI, stop and start a different BP med; give antihistamine bc its a localized reaction
ACE & ARBS
Contraindication
ARBS excreted fecally more than renal
Cause with other BP meds
C/I in pregnancy; Category C
- avoid K+ sparing diuretics bc ACEI causes changes with Na and K
- If K is high in ACEI, double check, if still high -> reduce dose a little bit
ACE & ARBS
indications
HTN (esp w/ DM): 1st line agent
1st line for DM bc of renal protection
CHF: A2 and inflammation, remodeling -> cardiac changes; preload reducer, afterload reducer
Microalbuminuria: >19 is pathological; reason pts with DM but not HTN might be put on low dose ACEI or ARBS –> decrease arterial deconstruction in kidneys; helps improve perfusion bc less pressure in kidneys
Post MI, ACS, LVEF <40%
ACEI & ARBS
Monitoring
Potassium: make sure not elevated in first week and check again in 1 month
Angioedema esp w. macrolides
Don’t prescribe macrolide w/ ACEI if pt has infections
Check liver function
Check renal function
CCB
Most potent class of BP reduction
Nondihydropyridines: Type 1 receptors
- verapamil and diltiazem
Dihydropyridines: Type 2 receptors
- pines
CCB
Mechanism of action
Inhibit Ca+ movement at smooth muscle cell membrane
- Arterial vasodilation
- Decreased contractility
- Decreased afterload
- No impact on preload (no venous impact)
Nondihydropines: slow AV node conduction; verapamil can be given sublingual; monitor BP closely; slow HR
Dihydropines: vasodilator; little/no effect on HR; may cause reflex tachycardia if BP drops too low
CCB
Pharmacokinetics
All absorb well PO, OK with food
Nondihydropines
- rapid metabolism and bioavailability quickly (verapamil)
Dihydropines: varying ,metabolism and absorption
- Amlodipine 65-90%: well absorbed; high metabolism (works quickly), long half-life
Isradipine 15%: poor absorption and bioavailability
CCB
Pharmacokinetics
Rarely cross blood brain barrier; don’t have sedative properties
All cross placenta
Excreted in breast milk, except Nifedipine
Hepatic metabolism: broken down in liver
Fecal and renal excretion
Short 1/2 life if not sustained release formulation; need to be taken multiple times daily
Norvasc (amlodipine): long half life; good agent to use for daily dosing
CCB
Adverse reactions
Nondihydropine: chronotropic effect - low HR and arrhythmia related to low HR or alteration in conduction or velocity
Peripheral edema: vasodilation lets blood pool -> vascular permeability; elderly more prone
Constipation: gut is primarily smooth muscle; effects musculature and contraction of gut; peristalsis slows; elderly more prone
Worsen GERD - interferes with muscle contraction of lower esophageal sphincter -> increased reflux
Flushing, HA, low BP, edema, reflex tachycardia
CCB
Sustained release formulas are most effective; most predictive metabolism and lowest rate of side effects; most predictive bioavailability; long acting prevents BP fluctuations
Amlodipine: not sustained release; long acting and stable when crushed (good for pt w/ dysphasia); not excreted quickly; can be given once daily
C/I in pt w/ HF!!! Not used immediately post ACS. Can worsen wolf Parkinson white syndrome (conduction disturbance)
Category C
Amlodipine Category D
Check hepatic function before therapy: metabolized almost entirely in liver
CCB
Indications
Tachycardia dysrhythmias
-rate control for SVT, afib, (verapamil & diltiazem)
HTN
migraine prophylaxis (30% improvement)
Vasospastic angina (stable) bc of vasodilation effects
Raynauds: peripheral arterial spasms in cold weather; vasodilation
Esophageal spasm: lower esophageal sphincter relaxes w/ vasodilation of smooth muscle
Diuretics
Thiazides
Loop diuretics
K+ sparing
Decrease volume
decreased preload
decreased pressure arterial bed
Diuretics
Thiazides
Inhibit Na, K, Cl, and bicarb reabsorption in distal tubule of nephron. H2O follows electrolytes out of body.
Effect is increased Ca and uric acid
Electrolyte imbalance: low K
Increased glucose bc of dehydration
Muscle cramps: due to increased Ca, paresthesias, impotence.
Avoid in gout to prevent uric acid buildup
Diuretics
Thiazides
Chlorthalidone (Hygroton): very long 1/2 life (~50 hrs), very effective
Hydrochlorothiazide (Microzide, Hyrodiuril)
Indapaminde (Lozol)
Metolazone (Zaroxolyn): not as effective in pt with renal impairment; with gfr < 25 or low creatinine clearance NOT effective
Diuretics
Loop
Work in loop of Henle in kidney; action happens sooner in kidneys than later in tubules where thiazides work. Have more substantial diuretic effect; helpful for pt with kidney function impairment and low gfr
Furosemide (lasix)
Bumetanide (Bumex)
More substantial diuresis
0.5 - 1 hr 1/2 life
More K loss; will need to replace K more often than with thiazide
Indicated for edema with CHF
Diuretics
K sparing
Alter Na reabsorption in distal tubules in nephron further than where K is reabsorbed; reason K sparing diuretics let go of Na and not K
Triamterene
Spironolactone
Improve edema in CHF
Na depletion: watch for low Na
Avoid in ACE or ARB bc they hold onto K –> hyperkalemia
Diuretics
Preload reducers
Long term: reduce volume -> decreased SVR and afterload
Diuretics
Pharmacokinetics
Triamterene not absorbed as well as others. All effect electrolytes
Enter blood AND extracellular spaces
Liver metabolizes diuretics; Furosemide is both hepatic and non hepatic
All excreted in urine, some feces
Diuretics
Adverse reactions
Electrolyte imbalances
Glucose intolerance
Hyperuricemia: concern for gout pt
Dehydration and hypotension -> falls
Drug interactions
Diuretics
C/i
No K sparing diuretics in pt with renal impairment -> high K; Creatinine clearance < 25 - 30 avoid
Patients w/ gout: high uric acid -> flairup
High risk for falls: urge to go to bathroom is high
Dehydration
Diuretics
Indications
HTN: 1st line
Prevent CV complications: decrease volume and likelihood of developing CHF
Selection based EGFR
> mid 40s ml/min: Thiazides (good egfr)
< mid 40s ml/min: Loops (moderately low egfr)
If profoundly low send to nephrology
Diuretics
Indications
Edematous conditions
CHF: in addition to ACE (except K sparing)
Hepatic cirrhosis: abd ascites and lower extremity edema due to hepatic congestion
Renal impairment: Loop are most effective
Premenstrual edema: Gyn prescribes
Take 3-5 days before menses; stop once menses begins
Beta adrenergic blocker
“olol”
Beta 1: CV; SA node, atria, ventricles - increase HR or increase rate of contraction
Beta 2: Pulmonary; mediate smooth muscle contraction and constriction
Nonselective beta blockers: influence cells in lungs and in heart -> bronchiole smooth muscle contraction will exacerbate asthma symptoms
Nebivolol: most selective can affect poor metabolizers and not affect BP –> build up in system (not used often)
Atenolol: second most selective
Metoprolol: third most selective
All 3 have long half lives
Beta blockers
Mechanism of action
Prevent catecholamines (epi, norepinephrine) and beta agonists (albuterol) from binding to sites of activity
Receptor site located on CV, renal, opthalmologic, and respiratory systems
Some effect in pancreas and metabolism of fat -> elevated triglycerides and cholesterol and lower HDL
DM pts might have elevated hA1C bc of effect on pancreas
SA node to reduce HR to slow automaticity of heart
AV junction to reduce conduction velocity so impulse is not conducted quickly through junction
Atria and ventricles to reduce contractile force (negative isotropism) to decrease workload and O2 demand of heart
Beta blockers
Pharmacokinetics
Well absorbed PO, first pass metabolism
Widely distributed into tissues, placenta, and breast milk
CNS penetration with Timolol, Metoprolol, and Propranolol -> sedation
Nebivolol is very lipophilic, some CNS penetration -> some sedation
Hepatic metabolism
Excreted in bile, feces, urine
Nadolol, atenolol, and nebivolol require dose adjustments in diminished renal function; excreted in urine
Beta blockers
Adverse reactions
Bronchospasm: shouldn’t prescribe in pulmonary diseases
Most are pregnancy category C or D
Sotalol, Acebutolol, Pindolol are Category B
Metoprolol has very low excretion in breast milk; safer for breastfeeding mom
Rebound symptoms with discontinuation; taper slowly
Impotence: no erection, inability to maintain erection; beta blocker not first choice in men unless not sexually active (CHF)
Beta Blockers
Indications
Long term angina management
Rate control in dysrhythmias
Heart failure & HTN: reduce workload of heart and decrease O2 demand
Post ACS: reduce workload of heart and decrease O2 demand
Migraine prophylaxis, hyperthyroidism: tx of racing heart while leveling out thyroid levels
Beta Blockers
C/i
Pulmonary disease
AV block or sick sinus syndrome: slowed condition and prolonged PR intervals
Avoid in pt w/ DM or pre DM: will negatively impact glucose control
Children: atenolol and propranolol have approved dosing schedules
Induce cytochrome P2D6 which is used to metabolize Prozac and Paxil; pick a different SSRI if pt needs to be on beta blocker
Alpha Receptors
Sympathetic NS: fight or flight
Parasympathetic: Rest and relax
Alpha Receptors stimulated by norepinephrine (SNS) from brain
Alpha 1 receptors:
- vascular walls, heart, eye, salivary glands, sphincters, Kidney, ureter, bladder, male sex organs
- increased HR, increased urgency to void
Alpha 2 receptors:
- arterioles of the skin and mucosa (dry mouth), pancreas
- fat cells (inhibit lypolysis)
Alpha Agonists
Mechanism of action
Alpha 1
Alpha 1 agonists: epi and norepi signal heart, smooth muscle and CNS
Primary receptor on vascular smooth muscle: potent vasoconstrictor, increase HR
Naturally occurring catecholamines: epi, norepi, and dopamine
Nasal spray: oxymetazalone: typical decongestant -> spray in nare; phenylephrine
PO ephedrine: decreases nasal decongestion and treats bronchospasm in asthma; banned in 2003 due to risk of insomnia, stroke, HTN, urine retention
Pseudoephedrine: vasoconstriction in nasal passages and elsewhere in body; decreases nasal congestion but not used with HTN or arrhythmias
* must present ID to pharmacist to purchase due to use in making meth
Alpha Agonists
Mechanism of action
Alpha 2
Stimulate alpha 2 receptors in brain that activate inhibitory neurons to prevent release of norepi
Prevent/reduce central sympathetic tone
Inhibit cardiac acceleration and vasoconstriction centers in brain
Decrease peripheral outflow of norepi -> vasodilation
Decreased PVR, RVR, HR, BP
Compensatory effects: Na and H2O retention to increase volume -> edema in brain
Alpha 2 agonists
Clonidine (Catapres): PO or weekly patch; SL in hypertensive crisis; epidural by anesthesia
Guanabenz (Wytensin): not typically used
Methyldopa (Aldomet): can change central concentration in brain; affect tissue concentration in serotonin, dopamine, epi, norepi
- prescribed for mood changes
- preferred BP med for pregnant women; Category B